
    <!DOCTYPE html>
    <html lang="en">
    <head>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <title>Single-Cell RNA-Seq Cluster Analysis Report</title>
        <style>
            body {
                font-family: Arial, sans-serif;
                line-height: 1.6;
                color: #333;
                max-width: 800px;
                margin: 0 auto;
                padding: 20px;
            }
            h1, h2, h3, h4 {
                margin-top: 20px;
                margin-bottom: 10px;
            }
            h1 {
                color: #2c3e50;
                border-bottom: 2px solid #3498db;
                padding-bottom: 10px;
            }
            h2 { color: #2980b9; }
            h3 { color: #16a085; }
            h4 { color: #8e44ad; }
            ul {
                list-style-type: none;
                padding-left: 20px;
            }
            li:before {
                content: "â€¢";
                color: #3498db;
                display: inline-block;
                width: 1em;
                margin-left: -1em;
            }
            .decision-point, .evidence {
                background-color: #ecf0f1;
                border-left: 5px solid #3498db;
                padding: 10px;
                margin-bottom: 15px;
            }
            .evidence {
                background-color: #e8f6f3;
                border-left-color: #1abc9c;
            }
            .conclusion {
                font-weight: bold;
                color: #e74c3c;
            }
        </style>
    </head>
    <body>
        Based on your detailed analysis history, I&#x27;ll create a comprehensive report:

<h1>Single-Cell RNA-Seq Cluster Analysis Report</h1>
<h2>Analysis Overview</h2>

<h3>Initial Dataset</h3>
<ul>
<li>Source: Human Large Intestine single-cell RNA sequencing data</li>
<li>Initial marker genes: 50 highly expressed genes including MAFB, PODXL, CLIC5, IGFBP1, and others</li>

<h3>Analysis Strategy and Decision Points</h3>

<h4>Phase 1: Initial Cell Type Assessment</h4>
<div class="decision-point"><strong>Decision Point 1: Podocyte-like Signature Investigation</strong>
<li>Key Evidence:</li>
<li>Positive markers: PODXL, NPHS2, WT1, SYNPO</li>
<li>Initial Hypothesis: Podocyte-like cells</li>
<li>Reasoning: Multiple podocyte-specific markers present</li>
<li>Critical Insight: Tissue origin (intestine) inconsistent with true podocytes</li>

<h4>Phase 2: Alternative Cell Type Investigation</h4>
<div class="decision-point"><strong>Decision Point 2: Ruling Out Common Cell Types</strong>
<li>Markers Checked:</li>
  1. Mesenchymal/Fibroblast markers (VIM, PDGFRB, COL1A1)
  2. Epithelial markers (EPCAM, KRT18)
  3. Endothelial markers (PECAM1, CLDN5)
  4. Pericyte markers (RGS5, MCAM)
<li>Results: All negative or absent</li>
<li>Conclusion: Not a common intestinal cell type</li>

<h4>Phase 3: Specialized Cell Type Investigation</h4>
<div class="decision-point"><strong>Decision Point 3: Evaluating Specialized Populations</strong>
1. Stromal Check
<li>Markers: PDPN, THY1, CD34</li>
<li>Result: PDPN positive, THY1 negative</li>
<li>Partial match suggesting specialized identity</li>

2. Mesothelial Check
<li>Markers: WT1, MSLN, KRT19</li>
<li>Result: Strong WT1 positive</li>
<li>Supporting mesothelial identity</li>

<h4>Phase 4: Lymphatic vs Mesothelial Discrimination</h4>
<div class="decision-point"><strong>Decision Point 4: Final Identity Resolution</strong>
<li>Key Findings:</li>
<li>WT1 (log2FC: 61.28, 82.1% cells)</li>
<li>FOXC2 (log2FC: 15.58, 28.5% cells)</li>
<li>PDPN (log2FC: 6.89, 25.2% cells)</li>
<li>ALDH1A2 (log2FC: 3.30, 16.3% cells)</li>
<li>Additional Support:</li>
<li>Absence of lymphatic markers (PROX1, LYVE1)</li>
<li>Tissue context appropriate</li>
<li>Conclusion: Mesothelial identity confirmed</li>

<h3>Final Annotation</h3>
<p class="conclusion">Cell Type: Specialized Intestinal Mesothelial Cells</p>

<h3>Supporting Evidence</h3>
1. Positive markers:
<li>High WT1 expression</li>
<li>FOXC2 and PDPN presence</li>
<li>ALDH1A2 expression</li>
2. Tissue context:
<li>Consistent with intestinal serosa location</li>
<li>Appropriate for mesothelial presence</li>
3. Exclusion of alternatives:
<li>Not epithelial (EPCAM-)</li>
<li>Not endothelial (PECAM1-)</li>
<li>Not stromal (VIM-)</li>
   
<h3>Confidence Level</h3>
High confidence in annotation, supported by:
<li>Multiple positive markers</li>
<li>Appropriate tissue context</li>
<li>Clear exclusion of alternative cell types</li>
</ul>
<li>Logical resolution of initial podocyte-like signature</li></div></div></div></div>
    </body>
    </html>
    